Pluricentric randomized study comparing two therapeutic strategies at beginning of Crohn's
disease: early immunosuppressants (prescription within the six first months following
diagnosis) vs. conventional strategy (immunosuppressants given only in case of steroid
failure, in a selected group of patients being at high risk of disabling course. The
hypothesis is that immunosuppressants given early may improve the disease course during the 3
following years in this subset of patients.
Phase:
Phase 4
Details
Lead Sponsor:
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives